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512 The Journal of Thoracic and CardioObjective: The present study investigated the outcomes of aortic valve replacement with
17-mm mechanical prostheses in patients with isolated aortic stenosis.
Methods: Between January 1997 and January 2003, 35 patients (mean age, 63.4  17
years; median age, 70 years; age range, 16-84 years) underwent isolated aortic valve
replacement with a 17-mm St Jude Medical Hemodynamic Plus (16 [45.7%] patients)
or a St Jude Medical Regent prosthesis (19 [54.3%] patients). The paired Student t test
or the paired Wilcoxon rank sum test were used to compare preoperative with follow-up
echocardiographic measurements.
Results: Thirty-two (91.4%) patients were female, mean height was 154.4  8.3 cm,
mean weight was 62.2 9.2 kg, and mean body surface area was 1.59 0.13 m2. The
preoperative average New York Heart Association class was 2.8  0.8. The mean
preoperative left ventricular mass index was 135.2  31 g/m2. Preoperative echocar-
diography showed an average gradient of 65.7 19.2 mm Hg (mean) and 103.6 30.7
mm Hg (peak) and a mean indexed effective orifice area of 0.40  0.1 cm2/m2.
Echocardiographic follow-up time averaged 28.2 22.7 months (range, 13-72 months).
Follow-up was 100% complete (1131.7 patient-months). Hospital mortality was 8.6% (3
patients). Actuarial 5-year survival was 94.7%. The mean postoperative New York
Heart Association class was 1.13  0.34 (P  .001), with 27 (87.1%) patients in class
I and 4 patients in class II. A significant regression of the indexed left ventricular mass
was found (postoperative mean value, 107.8  22.8 g/m2; P  .0001), despite a mean
indexed effective orifice area of 0.67  0.14 cm2/m2 (median, 0.66 cm2/m2).
Conclusions: Selected patients with aortic stenosis can experience satisfactory clinical
improvement and significant indexed left ventricular mass regression after aortic valve
replacement with modern small-diameter bileaflet prostheses.
Aortic valve replacement in patients with a small aortic root isstill a challenge for the cardiac surgeon. Since 1978, whenRahimtoola1 first pointed out the threat of poor outcome inpatients receiving small aortic prostheses, an intense debate hasdeveloped on this topic without a uniform conclusion. Althoughsome studies2-4 have suggested the possibility that the increased
morbidity and mortality in this subset of patients has to be mainly ascribed to
patient-related factors rather than valve-related factors, others5-8 show a significant
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and clinical outcome. Some studies6 have shown decreased
symptom relief, poor regression of left ventricular mass, and
decreased survival with an indexed effective orifice area
(EOAI) of less than 0.85 cm2/m2, whereas others5 have
shown such results with an EOAI of less than 0.75 cm2/m2.
Several surgical strategies can be applied to avoid the
feared PPM. These strategies include the use of root-en-
largement procedures, stentless bioprostheses, or modern
mechanical valves with an improved hemodynamic profile.
Reports about the effect of some of these strategies fail to
point uniformly toward an improved outcome.9 Authorita-
tive reports have demonstrated a marked, although not sta-
tistically significant, early mortality increase after aortic
root-enlargement procedures9 without a superiority in long-
term results and therefore suggested the use of stentless
prostheses in the small aortic root. In contrast, other au-
thors10 have claimed minimal added 30-day risk with root
enlargement when compared with isolated aortic valve re-
placement. Results from different randomized comparisons
between stented and stentless bioprostheses have failed to
show a uniform conclusion: some studies11,12 show equal
performance between the 2 types of prostheses, whereas
others13 show a superior performance of stentless biologic
valves. Prospective investigations evaluating clinical out-
comes of stentless aortic valve replacement in patients with
a small aortic annulus are lacking. Some authors have
shown the superiority of mechanical over biologic prosthe-
ses in this patient subset.5 Good results are reported, espe-
cially when bileaflet prostheses with improved hemodynam-
ics14-16 are implanted. The aim of this study was to evaluate
the short-term clinical and echocardiographic outcomes of
aortic valve replacement with 17-mm St Jude Medical me-
chanical prostheses (Hemodynamic Plus [HP] and Regent
models; St Jude Medical, Inc, St Paul, Minn) in a population
of patients referred to our center for aortic valve stenosis.
Characteristics of our study population were in accordance
with those of populations studied in other series,17,18 show-
ing that patients in whom the option of a small aortic
prosthesis for aortic valve replacement is feasible are mostly
small elderly women.
Patients and Methods
Study Population
Between January 1997 and January 2003, 1235 isolated aortic
valve replacement procedures with mechanical prostheses were
performed in our hospital. A 17-mm St Jude Medical valve was
implanted in 55 (4.4%) cases: from 1997 through 2000, 27 patients
received an HP model, and between 2001 and 2003, 28 had a
Regent model implanted. Of those 55 cases, 20 patients with
associated procedures (other than coronary artery bypass grafting)
were excluded, and thus 35 patients entered the study. Among
them, 32 (91.4%) were female, with a mean age of 63.4 17 years
(median age, 70 years; age range, 16-84 years) and a mean body
The Journal of Thoracisurface area (BSA) of 1.59  0.13 m2. Anthropometric features
are shown in Table 1. All 35 patients underwent operations for an
isolated aortic stenosis. Symptoms at admission included angina in
31.4% of patients and syncope or arrhythmia in 8.6% of patients.
In 3 asymptomatic patients a surgical procedure was indicated for
calcific appearance of the stenotic valve at echocardiography19 and
high transvalvular gradients. Mean preoperative New York Heart
Association class was 2.8  0.8. Preoperative clinical features are
shown in Table 1. The incidence of associated coronary athero-
sclerosis was 11.4%, as detected by means of coronary arteriog-
raphy, and peripheral atherosclerosis (involvement of the supra-
aortic vessels or lower-limb arteries) was found in 8.6%. The most
common cause of the aortic stenosis was degenerative (62.9%).
Three (8.6%) patients had previously undergone cardiac surgery.
Mean EuroSCORE (calculated according to the additive Euro-
SCORE model20) in the present study population was 4.45 2.95.
Echocardiography
Standard M-mode dimensions were collected according to the
criteria of the American Society of Echocardiography. All Doppler
measurements were obtained as the average of at least 3 cycles in
patients with sinus rhythm or more than 5 cycles in those with
atrial fibrillation. The peak and mean gradients across the prosthe-
TABLE 1. Preoperative data
Age (y), mean  SD (median
[range])
63.4 17 (70 [16-84])
Height (cm), mean  SD (median
[range])
154.4 8.3 (155 [136-173])
Weight (kg), mean  SD (median
[range])
62.2 9.2 (62 [40-85])
BSA (m2), mean  SD (median
[range])
1.59 0.13 (1.59 [1.21-1.80])
BMI, mean  SD (median
[range])
26.42 4.53 (25.8 [20.13-37.78])
NYHA class
I 3 (8.6%)
II 6 (17.1%)
III 21 (60%)
IV 3 (8.6%)
Cardiogenic shock 2 (5.7%)
Female sex 32 (91.4%)
Aortic valve disease
Degenerative 22 (62.9%)
Congenital 10 (28.6%)
Rheumatic 2 (5.4%)
Other 1 (2.9%)
Hypertension 21 (60%)
Diabetes 4 (11.6%)
Obesity 7 (20%)
Atherosclerosis 4 (11.6%)
Severely calcified annulus 25 (71.4%)
EuroSCORE, mean  SD (median
[range])
4.45 2.95 (4 [0-14])
BSA, Body surface area; BMI, body mass index; NYHA, New York Heart
Association.sis were calculated according to the modified Bernoulli equation.
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continuity equation: (LVOT2  0.785  TVI1)/TVI2, where
LVOT is the diameter of the left ventricular outflow tract and TVI1
and TVI2 are the time-velocity integrals at the left ventricular
outflow tract and across the aortic valve respectively. The left
ventricular mass index (LVMI) was calculated from Reichek’s
formula.21 BSA was calculated according to the Dubois formula.
Preoperative echocardiography was available in 100% of patients.
Preoperative ejection fraction (EF) averaged 58.1%  13%, with
3 patients having a preoperative EF of less than 40%. Mean
preoperative LVMI was 135.2  31 g/m2. Preoperative hemody-
namic data, as detected at transthoracic echocardiography, are
reported in Table 2.
Surgical Technique
The operation was always performed through a median sternot-
omy, with moderate systemic hypothermia and use of cold potas-
sium cardioplegia and pericardial topical cooling. Prosthesis size
was selected according to the size of the aortic annulus, which was
determined by using the manufacturer’s sizer. In 2 cases, for
technical reasons, a 17-mm prosthesis was implanted, although the
manufacturer’s sizer indicated a 19-mm annulus size. Prostheses
were implanted with single interrupted sutures. Regent model
prostheses were implanted supra-annularly. Teflon pledgets were
used when needed (5.7% of cases). Valve prostheses were im-
planted with their axis perpendicular to the interventricular sep-
tum. Implanted prostheses were St Jude Medical HP in 16 (45.7%)
patients and SJM Regent in 19 (54.3%) patients. The annulus was
severely calcified in 71.4% of cases, and additional surgical de-
bridement of the left ventricular outflow tract, the anterior mitral
leaflet, and/or the left coronary ostium was performed in 20.4% of
cases. Coronary artery bypass grafting procedures were associated
in 5 (14.5%) patients.
After the second postoperative day, patients received oral an-
ticoagulation with sodium warfarin at daily updated dosages ac-
cording to international normalized ratios. The target international
normalized ratio value was in accordance with American College
of Cardiology/American Heart Association guidelines.
Follow-up
Patients were followed up by the cardiologists of our echocardi-
ography outpatient clinic at a mean postoperative time point of
Table 2. Echocardiographic preoperative and postoperativ
Preoperative
Maximum gradient 103.6 30.7 (100 [45-124])
Mean gradient 65.7 19.2 (68 [25-76])
LVMI 135.2 31 (135.1 [73-144])
EOA 0.63 0.18 (0.63 [0.41-1.05])
EOAI 0.40 0.10 (0.39 [0.22-0.59])
EF 58.1  12.6 (60 [25-70])
All data are presented as means  SD (median [range]). LVMI, Left ventri
EF, ejection fraction.
*Paired t test.28.2  22.7 months (median, 21.6 months; range, 13-72 months).
514 The Journal of Thoracic and Cardiovascular Surgery ● MarBoth clinical (New York Heart Association class evaluation) and
echocardiographic (maximum and mean gradients, EOAI, and
LVMI) assessments were scheduled by protocol at the sixth post-
operative month and yearly thereafter. Clinical follow-up was
updated to May 2004 through telephone interview for all patients.
In case of new-onset symptoms, additional echocardiography ex-
aminations were performed, and the patient’s follow-up charts
were updated accordingly.
Echocardiographic follow-up was 100% complete. Definition
of valve-related events and anticoagulation-related complications
was made according to Edmunds’ criteria.
Statistical Analysis
The SPSS software (version 10.1; SPSS Inc, Chicago, Ill) was used
for statistical analysis. Continuous variables were expressed as
means  SD, whereas categorical variables were expressed as
counts and percentages. The paired Student t test or the paired
Wilcoxon rank-sum test in case of asymmetric distributed data was
used to compare echocardiographic data measured preoperatively
with those found at follow-up. Actuarial survival was calculated by
using the mean of the Kaplan-Maier method and expressed as
percentages  SE.
Results
Clinical Follow-up and Valve-Related Events
Clinical follow-up showed an actuarial survival of 88.6%
0.07% at 5 years (mean follow-up time, 35.4  22.3
months; 1131.7 patient-months). Three patients died within
30 days of the operation (hospital mortality, 8.6%). In 2
cases death occurred soon after the operation because of low
cardiac output syndrome. One patient who postoperatively
had a stroke died of respiratory failure. The early postop-
erative period was complicated in 1 patient by bleeding
requiring surgical revision and in another patient by atrio-
ventricular block requiring pacemaker implantation. One
female 82-year-old patient died 1 year postoperatively of
complications of an amyotrophic lateral sclerosis. There
was no structural failure of the prostheses, no paravalvular
leak, and no prosthetic endocarditis. Freedom from reopera-
ta
Follow-up
P
value*
36.8 12.2 (38.5 [18-61]) .001
21.8 7.8 (22.5 [11-37]) .001
107.8 22.8 (103 [70-188.6]) .001
1.05 0.24 (1.04 [0.58-1.63]) .001
0.67 0.14 (0.66 [0.47-0.97]) .001
59.2 6 (60 [50-75]) .545
mass index; EOA, effective orifice area; EOAI, effective orifice area index;e da
culartion was 100%. No valve-related or anticoagulation-related
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preoperative and postoperative clinical status.
Echocardiographic Follow-up
Echocardiographic results are displayed in Table 2. A sig-
nificant reduction in maximum and mean gradients was
observed in all patients, with a mean difference versus
preoperative values of 66.8 25.6 mm Hg (95% confidence
interval [CI], 57.4-76.3) and 43.9  19 mm Hg (95% CI,
36.9-49.8), respectively. A statistically significant reduction
in mean ventricular mass values was found (P  .0001),
with a mean difference of 27.4  25.7 g/m2 (95% CI,
16.5-36.1). Only in 4 (12.5%) patients did LVMI increase
postoperatively. In 19 female and 3 male patients (68.7%)
LVMI normalized. In 5 (15.6%) patients postoperative
LVMI ranged between 110 and 125 g/m2. In the other 5
patients postoperative LVMI was greater than 125 g/m2.
No significant difference between preoperative and post-
operative mean EF was observed. In the 3 patients with
preoperative EF of less than 40%, ventricular function
showed a trend toward recovery to normal values postop-
eratively.
Discussion
Hospital mortality in our series is consistent with that of
published studies on similar patient populations receiving
small-diameter mechanical prosthetic valves,17,22 which is,
however, a higher rate than generally reported for aortic
valve replacement. In a large series by Blackstone and
colleagues,23 patient prosthesis size of less than 1.2 cm2/m2
was associated with a 1% to 2% increase in 30-day mortal-
ity. A recent study by Blais and associates8 demonstrated
that PPM is a risk factor for in-hospital mortality, with the
most prevalent cause of death being low-output syndrome.
This was the cause of death in 2 of the 3 patients who died
in the hospital in the present report. However, our mortality
rate of 8.6% could also be explained by the relatively high
mean and median preoperative EuroSCORE values. In a
large series of geriatric patients,24 the use of small valves
was not an independent risk factor for early mortality,
whereas small BSA was among the significant predictors of
hospital death. In the present study only 2 models of the St
Jude Medical mechanical bileaflet prosthesis were im-
planted. The St Jude Medical Regent model, when com-
pared with the same size St Jude Medical HP model, shows
increased orifice dimensions because of modified external
geometry of the orifice housing.25 Despite good in vivo
performance,16,26 clear evidence of the long-term clinical
superiority of the Regent model has not yet emerged. In the
present study no significant difference was found in terms of
preoperative and follow-up LVMI between the 2 models
implanted, probably because of the exiguity of the subpopu-
lations.
The Journal of ThoraciIn an authoritative editorial4 commenting on the favor-
able experience of Sawant and coworkers18 with small
mechanical prostheses, the role of patient baseline charac-
teristics was emphasized. Medalion and associates,3 report-
ing on a series of 892 patients, maintained that survival after
aortic valve replacement might be related to patient risk
factors but not adversely affected by moderate PPM. Pa-
tients with associated aortic valve regurgitation or mitral
valve disease were excluded from the present study in an
attempt to minimize the effect on left ventricular mass
regression of associated conditions that were considered, in
a critical article by Christakis and Goldman,4 a source of
sample heterogeneity and therefore of relevant bias. As far
as hypertension is concerned, it was present in about 60% of
our patients: all of them were postoperatively treated with
antihypertensive drugs, and blood pressure control was sat-
isfactory (normal values or sporadic mild hypertension at
each follow-up visit and telephone interview). Our study
population presented with high mean age and was charac-
terized by low daily physical activity (the patient aged 16
years was affected by Turner syndrome and chronic renal
failure treated with hemodialysis) and very low mean
height. Although the mean BSA could be considered not so
low, with body mass index values being relatively high, it
has been previously pointed out that the annular diameter
relates significantly better to height than to BSA.27 A mean
EOAI of 0.67 could probably determine a more severe
mismatch in taller patients with the same BSA.
The most interesting result of this study was the significant
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Figure 1. Functional New York Heart Association class assess-
ment data before and after aortic valve replacement with 17-mm
bileaflet prostheses.regression of mean LVMI, despite the realization of a moder-
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patients), consistently with transprosthetic maximum gradients
that are reasonable for small-diameter prostheses (mean and
median, 22 mm Hg). The reliability of Doppler measurements
of transprosthetic gradients has been reconsidered by some
authors,28 showing that the particular transprosthetic flow and
velocity distribution could induce an overestimation of the
values when compared with invasive methods. Patients not
showing a complete regression of LVMI should undergo
deeper investigations. Freed and colleagues,17 in a population
of small, elderly patients, explained the excellent results in
terms of mass regression with their low preoperative LVMI
(114 g/m2). Although our patients’ mean preoperative LVMI
value did not represent an impressive left ventricular hypertro-
phy grade, 135 g/m2 is to be considered high for a predomi-
nantly female population, also in view of the very low mean
height. Indeed, in some of our patients, a delay in surgical
referral might have occurred: this is revealed by the high
prevalence of severely calcified annulus (71.4% of patients)
that should represent an indication for surgical intervention in
an asymptomatic elderly patient.19 Preoperative functional sta-
tus was quite poor, implying a high prevalence of advanced-
stage disease with diastolic dysfunction. In 3 patients systolic
dysfunction (EF45%) was present also. With these baseline
conditions, the possibility of complete left ventricular regres-
sion is questionable because interstitial relative fibrosis is sup-
posed to be preoperatively increased.29 Stratification on the
basis of preoperative clinical status could be useful but was not
feasible in this study because of the small sample dimensions.
As regards clinical outcomes of aortic valve replacement
with 17-mm St Jude Medical prostheses, we observed good
functional recovery in most patients, which is consistent
with the data about LVMI regression. Our clinical results
seem to be in discordance with those most recently for-
warded by Ruel and coworkers,30 claiming that PPM is a
significant predictor of postoperative congestive heart fail-
ure symptoms. Unfortunately, because of the different fol-
low-up lengths and the lack of any LVMI regression anal-
ysis in that study, it is not possible to make comparisons
with our study, which merely addressed the occurrence of
mass regression early after aortic valve replacement with
17-mm prostheses. It has been stated4 that aortic valve
replacement with a small bileaflet prosthesis could be
viewed as the substitution of a progressive disease with
another nonphysiologic condition that is, however, steadily
persistent and less severe. Further investigations on larger
series of aortic valve replacement, including all possible
PPM degrees, should be undertaken to assess which are the
determinants of LVMI regression or increase.
Some limitations of this study should be considered. The
retrospective approach to data collection might have en-
tailed an imponderable methodologic bias. The routine
echocardiographic and clinical controls were not always
516 The Journal of Thoracic and Cardiovascular Surgery ● Marprecisely attended by the patients at the scheduled time
intervals: this jeopardized the possibility of assessing the
influence of time on LVMI regression. Similarly, because
the 2 models were not implanted concurrently and a relevant
number of early follow-up data were unavailable for the HP
subgroup, no comparative evaluation between the 2 pros-
thetic models could be performed. A prospective design
would have allowed for repeated-measurements analysis of
variance on standardized time-interval examinations. Fur-
thermore, M-mode echocardiography is surely less accurate
than magnetic resonance imaging in the measurement of
LVMI; however, the unavailability of preoperative mag-
netic resonance imaging in our patients prevented any com-
parison with possible postoperative data. No exercise test
was performed because such an elderly study population as
ours is expected to have limited daily physical activity, and
the significance of valve performance at exertion in the
perspective of postoperative quality-of-life assessment is
thereby questionable.
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